Sequent Scientific Share Price

Sequent Scientific Share Price

NSE: VIYASH
|
Pharmaceuticals

₹ 232.21

-₹2.81 (-1.2%)
1D
Last updated 14 Oct, 2026, 13:08 IST

Sequent Scientific Share Price Today

As of 14 Oct 2026, Sequent Scientific share price is ₹232.21. The stock opened at ₹235.80, compared to its previous close of ₹235.02. During today's trading session, Sequent Scientific share price moved in the range of ₹231.95 to ₹235.80, with an average price of ₹233.88 for the day. Looking at its last 52-week, the stock has touched a low of ₹178.13 and a high of ₹298.00. On the performance front, Sequent Scientific share price has increased by 14.50% over the last six months and is up 8.59% on a year-on-year basis.

₹231.95
1.20% down today
₹235.80
1D LOW
1D HIGH

Sequent Scientific Returns Calculator

Volume
4,26,398
Average traded price
₹234.16
Last traded time
01:08:20 14 Oct
Last traded quantity
22
Circuit
L
H
₹188.02
₹282.02
52-week
L
H
₹178.13
₹298.00
Mkt Cap Cr
10,418.99
P/E
38.84
P/B
3.68
ROA
5.77%
ROE
7.07%
ROCE
13.01%
Quick Ratio
1.53
EV/EBITDA
14.9
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Viyash Scientific has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Viyash Scientific appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Viyash Scientific revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,76,300.5082.5521.164.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%0.9114.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%0.6853.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%1.3515.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%1.1512.47
Lupin89,628.8316.033.9614.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Sequent Scientific

Sequent Scientific Share Price
ISIN
INE807F01027
Sector Market Cap
₹ 10,418.99 Cr

Viyash Scientific Limited, formerly SeQuent Scientific Limited, is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. The Company has eight manufacturing facilities, based in India, Turkey, Brazil, Spain and Germany. It is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It specializes in analytical and bioanalytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It offers analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer-developed methods or in-house method development.

Sequent Scientific Financial Highlights

  • Revenue: Sequent Scientific reported revenue of ₹3,463.86 crore in FY26 vs ₹3,039.73 crore in FY25. It showed an increase of 13.95% on a yearly basis.
  • Operating Profit: Sequent Scientific reported an operating profit of ₹349.02 crore in FY26 vs ₹13.18 crore in FY25. It showed an increase of 2,548.10% on a year-on-year basis.
  • Net Profit: Sequent Scientific reported a net profit of ₹224.65 crore in FY26 vs ₹15.77 crore in FY25. It showed an increase of 1,324.54% on a yearly basis.

Sequent Scientific Quarterly Result Highlights

  • Sequent Scientific reported revenue of ₹954.67 crore in Jun 2026, compared with ₹935.88 crore in Mar 2026, representing an increase of 2.01% on a quarter-on-quarter (QoQ) basis.
  • Sequent Scientific reported an operating profit of ₹112.41 crore in Jun 2026, compared with ₹125.24 crore in Mar 2026, representing a decrease of 10.24% on a quarter-on-quarter (QoQ) basis.
  • Sequent Scientific reported a profit of ₹79.29 crore in Jun 2026, compared with ₹66.38 crore in Mar 2026, reflecting an increase of 19.45% on a QoQ basis.
  • The earnings per share (EPS) of Sequent Scientific stood at ₹4.09 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
61.31%
FII
4.50%
Other DII
0.83%
Retail and other
30.44%
Mutual funds
2.93%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20255.91%
Dec 20253.16%
Mar 20262.94%
Jun 20264.50%
1 day
-0.36%
1 week
+0.77%
1 month
-8.77%
1 year
+8.59%
3 years
+127.73%
5 years
+5.91%
Day
Open / Close
Change %
13 Oct 26
₹236.60 / ₹235.02
-0.36%
12 Oct 26
₹236.45 / ₹235.88
+0.78%
09 Oct 26
₹236.01 / ₹234.06
-0.76%
08 Oct 26
₹241.90 / ₹235.86
-2.04%
Show more

Sequent Scientific Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,420.31₹3,006.84₹1,369.73₹1,420.91
Other Income₹43.55₹32.89₹10.96₹6.39
Total Revenue₹3,463.86₹3,039.73₹1,380.69₹1,427.30
Total Expenses₹3,070.63₹2,944.99₹1,417.94₹1,500.16
Profit Before Tax₹349.03₹13.18-₹54.65-₹137.66
Tax₹124.37-₹2.59-₹25.03-₹15.68
Profit After Tax₹224.65₹15.77-₹29.61-₹121.98
EPS - Basic₹4.09₹0.54-₹1.44-₹4.88
EPS - Diluted₹4.01₹0.53-₹1.44-₹4.88

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹349.03₹13.18-₹54.65-₹137.66
Income before WC changes₹713.41₹467.81₹90.32₹83.06
Change in Assets-₹388.10-₹183.62-₹8.54-₹34.60
Change in Liabilities₹58.94₹109.48-₹37.14-₹17.01
Change in WC-₹329.16-₹74.15-₹45.67-₹51.61
Cash flow from Operations₹322.91₹344.80₹30.60₹16.81
Cash flow from Investing-₹84.12-₹447.22-₹5.92-₹64.96
Cash flow from Financing-₹123.33₹87.04-₹1.44₹32.23
Total Cash Flow₹115.46-₹15.38₹23.24-₹15.92
Cash (Start of the year)₹140.30₹156.18₹41.57₹57.50
Cash (End of the year)₹255.76₹140.30₹64.81₹41.57

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,373.84₹2,349.48₹729.45₹749.33
Current Assets₹2,254.55₹1,782.79₹810.94₹779.79
Total Assets₹4,628.39₹4,132.27₹1,540.38₹1,529.12
Current Liabilities₹945.90₹1,015.11₹626.99₹558.76
Net Current Asset₹1,308.65₹767.67₹183.95₹221.04
Non-Current Liabilities₹567.76₹552.22₹200.44₹221.18
Equity Capital₹3,114.73₹2,564.94₹712.96₹749.19
Total Equity & Liabilities₹4,628.39₹4,132.27₹1,540.38₹1,529.12

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,382.06₹1,310.34₹168.52₹222.69
Other Income₹66.26₹72.21₹45.98₹28.24
Total Revenue₹1,448.32₹1,382.55₹214.50₹250.93
Total Expenses₹1,287.89₹1,251.92₹208.48₹260.67
Profit Before Tax₹116.22₹49.17-₹0.24-₹9.75
Tax₹40.35-₹9.32-₹0.86-₹3.67
Profit After Tax₹75.87₹58.49₹0.62-₹6.08
EPS - Basic₹1.75₹1.36₹0.03-₹0.24
EPS - Diluted₹1.72₹1.34₹0.03-₹0.24

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹116.22₹49.17-₹0.24-₹9.75
Income before WC changes₹262.77₹269.97-₹18.43-₹10.23
Change in Assets-₹93.64-₹121.74-₹11.45₹71.40
Change in Liabilities-₹38.71₹57.46₹0.67-₹22.72
Change in WC-₹132.35-₹64.28-₹10.77₹48.68
Cash flow from Operations₹119.12₹187.95-₹26.94₹37.75
Cash flow from Investing-₹106.88-₹410.18₹5.47-₹50.70
Cash flow from Financing-₹7.06₹195.38₹22.32₹0.24
Total Cash Flow₹5.18-₹26.85₹0.84-₹12.71
Cash (Start of the year)₹15.79₹43.15₹0.08₹12.80
Cash (End of the year)₹20.97₹15.79₹0.93₹0.08

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,692.59₹2,680.41₹1,090.82₹1,047.75
Current Assets₹962.45₹839.33₹96.78₹75.02
Total Assets₹3,655.04₹3,519.73₹1,187.60₹1,122.77
Current Liabilities₹415.77₹509.10₹98.16₹61.61
Net Current Asset₹546.68₹330.22-₹1.38₹13.42
Non-Current Liabilities₹50.20₹102.22₹2.21₹2.80
Equity Capital₹3,189.07₹2,908.41₹1,087.23₹1,058.36
Total Equity & Liabilities₹3,655.04₹3,519.73₹1,187.60₹1,122.77
* All values are in INR Crore
Qty
Bid
60
232.05
14
232.03
21
232.02
40
232.01
34
232
Ask
Qty
232.22
106
232.23
127
232.24
141
232.25
63
232.26
38
Bid Total: 169
Ask Total: 475
Buy orders: 26%
Sell orders: 74%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
40.24
Neutral
ATR (14)
7.99
Neutral
STOCH(9,6)
35.6
Neutral
STOCH RSI (14)
60.93
Neutral
ADX(9)
21.29
Bearish
UO(9)
35.73
Neutral
ROC(12)
-4.46
Bearish
WillR(14)
-71.87
Neutral
Period
Simple value
Exponential vaue
5D
236.32
235.43
10D
234.95
236.92
20D
240.88
241.54
50D
255.4
249.82
100D
259.09
248.85
Volume trend — traded volume by day
14 Oct4L
13 Oct10L
12 Oct14L
9 Oct16L
8 Oct38L
7 Oct30L
Average19L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Sequent Scientific Share Price
Sequent Scientific
Pharmaceuticals
Add Stock
Add Another

Sequent Scientific Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.